Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
First-of-its-kind Clinical Trial Monitoring Service Launched for Cancer Patients
<p xss=removed>Specimatch, the first continual clinical trial monitoring service announces the launch of its web-based software service for cancer patients. Users can easily connect to clinical trials personally matched to the patient’s genetic and clinical profiles through Specimatch.com.</p> <p xss=removed>This software is a solution for patients and oncologists to tap into a complex landscape of breakthrough treatments with both accuracy an...
FDA grants breakthrough therapy designation to Toca 511 & Toca FC in Recurrent High Grade Glioma
<p>Tocagen’s new gene therapeutic formulations – Toca 511 & Toca FC – for treating recurrent and metastatic cancers, specifically High-Grade Glioma (HGG), received FDA’s “breakthrough therapy designation” and awaits a full approval post clinical trials next year.</p> <p>HGG is a malignant form of primary brain tumour that originates from glial cells of the brain. Glial cells provide the structural backbone of the brain and support the funct...
Generative Adversarial Autoencoders to Revolutionize New Medications
<p>An international group of computer scientists have developed a Generative Adversarial Autoencoders (AAE) for generating novel molecular finger prints with a defined set of parameters.</p> <p>A 7 layer AAE architecture with the latent middle layer serving as a discriminator was developed. As an input and output the AAE uses a vector of binary fingerprints and concentration of the molecule.</p> <p>In the latent layer, a neuron responsible ...
Benchling Announces Release of Its Molecular Biology 2.0 to Power High-Throughput Design for DNA, Proteins & CRISPR
<p xss=removed>Benchling, the next generation life science R&D software company announces the release of the first of its kind, Molecular Biology 2.0 system, which is an exceptional extension of its existing molecular biology suite.</p> <p xss=removed>It helps to power high-throughput sequence design for DNA, proteins, and CRISPR. Molecular Biology 2.0 incorporates batch sequence design, CRISPR design, and cloning software, as well as full-fle...
FDA Approves Novartis Kisqali® Femara® Co-Pack to treat metastatic breast cancer
<p>Novartis has announced that its Kisqali Femara Co-Pack, the first, and only currently available, combination pack with two prescription products in advanced breast cancer has received approval from the US Food and Drug Administration (FDA).</p> <p>The Kisqali Femara Co-Pack (ribociclib tablets; letrozole tablets) is used to treat hormone receptor-positive, human epidermal growth factor receptor-2 negative (HR+ / HER2-) advanced or metastati...
Australian Scientists Discover Breakthrough in Lung Cancer Treatment
<p xss=removed>Australian scientists have discovered a breakthrough in lung cancer treatment. They discovered the origin cell of a common form of lung cancer that kills thousands of smokers and non-smokers.</p> <p xss=removed>This would help to detect squamous cell lung cancer that accounts for up to 30 per cent of all lung cancers. Scientists will take years to complete the breakthrough.</p> <p xss=removed>They observed the cells in the ai...
New Liquid Biopsy Chip Allows to Trap Cancer Cells Easily
<p style="text-align:justify">Worcester Polytechnic Institute (WPI) researchers have developed a new chip that traps and identifies metastatic cancer cells within a tiny amount of blood drawn from a cancer patient. Liquid Biopsy technique helps to capture and identify tumour cells and/or DNA.</p> <p style="text-align:justify">This technology uses a simple mechanical method, which is efficient in trapping cancer cells than the micro fluidic app...
Aptar Pharma and Medtech firms to Develop Novel Auto-injector
<p style="text-align: justify;">Aptar Pharma, a segment of AptarGroup entered into an exclusive development and license agreement with BD (Becton, Dickinson and Company), a medtech firm, to jointly develop a novel auto-injector.</p> <p style="text-align: justify;">In developing this injector, Aptar Pharma uses its two-step auto-injector technology and prefillable syringes from BD.</p> <p style="text-align: justify;">Auto-injectors are designed ...
Heptares Therapeutics and Kymab Limited to Develop Novel Antibody Therapeutics
<p style="text-align: justify;">Heptares Therapeutics (also known as Heptares) and Kymab Limited have entered into a strategic collaboration to discover, develop and commercialise novel antibody therapeutics.</p> <p style="text-align: justify;">New therapeutics will target a number of G protein-coupled receptors (GCPRs) with an initial focus on immune-oncology (a new area in the treatment of cancer).</p> <p style="text-align: justify;">GPCRs ar...
Advent of High-Resolution 3D Images Makes For A Clearer View of DNA Segments
<p style="text-align:justify"><img src="https://www.pharmafocusasia.com/pfasiaadmin/upload//technotrends/1467203548-top-advent-of-high-thumb.jpg" style="float:left; padding-right:10px; width:35%" />Qualitative and high-resolution images premiered at the Berkley Lab as the fruit of the labour invested by the Department of Energy’s researchers there. They succeeded in captivating unparalleled and first-ever 3D High-Resolution images sourced f...
